Discontinuing Operations (Details Narrative) - USD ($) $ in Thousands |
1 Months Ended | 3 Months Ended | ||||
|---|---|---|---|---|---|---|
Nov. 02, 2022 |
Jan. 31, 2022 |
Sep. 30, 2022 |
Jun. 30, 2022 |
Mar. 31, 2022 |
Dec. 31, 2021 |
|
| Asset Impairment Charges | $ 388 | $ 1,500 | $ 4,300 | $ 20,200 | ||
| Goodwill, Written off Related to Sale of Business Unit | 2,200 | |||||
| Liabilities of discontinuing operations - current | 3,845 | 3,522 | ||||
| Increase of rightofuse asset | $ 1,000 | |||||
| Cancer Genetics Inc [Member] | ||||||
| Liabilities of discontinuing operations - current | $ 280 | $ 409 | ||||
| Trade Names [Member] | ||||||
| Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill) | 300 | |||||
| Customer Relationships [Member] | ||||||
| Impairment of Intangible Assets, Indefinite-Lived (Excluding Goodwill) | $ 1,800 | |||||
| Vivo Pharm Pty Ltd [Member] | Subsequent Event [Member] | ||||||
| Upfront cash payment received | $ 5,500 | |||||
| Upfront cash adjustment | 5,500 | |||||
| Upfront cash total | 4,400 | |||||
| Exit cost | 600 | |||||
| Agreed to retain liabilities | $ 357 | |||||
| X | ||||||||||
- Definition GainLoss on disposition of assets adjustment. No definition available.
|
| X | ||||||||||
- Definition increase decrease of right-of-use asset No definition available.
|
| X | ||||||||||
- Definition Amount of write-down of assets recognized in the income statement. Includes, but is not limited to, losses from tangible assets, intangible assets and goodwill. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount classified as assets attributable to disposal group held for sale or disposed of. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of expenses associated with exit or disposal activities pursuant to an authorized plan. Includes, but is not limited to, one-time termination benefits, termination of an operating lease or other contract, consolidating or closing facilities, and relocating employees, and termination benefits associated with an ongoing benefit arrangement. Excludes expenses associated with special or contractual termination benefits, a discontinued operation or an asset retirement obligation. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Amount of gain (loss) on sale or disposal of assets, including but not limited to property plant and equipment, intangible assets and equity in securities of subsidiaries or equity method investee. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount of divestiture of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of impairment loss resulting from write-down of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit to fair value. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition Amount classified as liabilities attributable to disposal group held for sale or disposed of. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount classified as liabilities attributable to disposal group held for sale or disposed of, expected to be disposed of within one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|